Jia Lu Wu
Director/Board Member at Chengdu Aixing Biotech Co. Ltd.
Jia Lu Wu active positions
| Companies | Position | Start | End |
|---|---|---|---|
Chengdu Aixing Biotech Co. Ltd.
 Chengdu Aixing Biotech Co. Ltd. Packaged SoftwareTechnology Services Chengdu Aixing Biotech Co. Ltd. is a company founded in 2013 that develops a point of care testing platform. The company is based in Chengdu, China. | Director/Board Member | - | - |
Shanghai Pinnacles Medical Technology Co., Ltd.
 Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Director/Board Member | - | - |
Career history of Jia Lu Wu
Statistics
International
| China | 3 |
Operational
| Director/Board Member | 2 |
Sectoral
| Technology Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Chengdu Aixing Biotech Co. Ltd.
Chengdu Aixing Biotech Co. Ltd. Packaged SoftwareTechnology Services Chengdu Aixing Biotech Co. Ltd. is a company founded in 2013 that develops a point of care testing platform. The company is based in Chengdu, China. | Technology Services |
Shanghai Pinnacles Medical Technology Co., Ltd.
Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Health Technology |
- Stock Market
- Insiders
- Jia Lu Wu
- Experience
